A meta-analysis for the role of proton pump inhibitor therapy in patients with laryngopharyngeal reflux
- 800 Downloads
We aimed to systematically review the randomized controlled trials (RCTs) regarding the therapeutic efficiency of proton pump inhibitor (PPI) therapy for laryngopharyngeal reflux (LPR). Randomized and placebo-controlled trials regarding the therapeutic efficacy of PPIs on LPR patients were systematically searched from MEDLINE, Cochrane Library, and EMBASE. Data were extracted from eligible studies meeting the inclusion criteria. Heterogeneity among these eligible studies was evaluated by the Q-statistic and I 2 test, based on which a fixed- or random-effects model was performed to pooled relative risks (RRs) for the response rate and standardized mean differences (SMDs) for reflux symptom index (RSI) and the reflux finding score (RFS). Potential publication bias was evaluated by trim and fill method. Totally, 13 RCTs including 831 LPR patients were eligible for this meta-analysis. Pooled results demonstrated that the total RSI significantly improved for patients who received PPI therapy by comparing with those receiving placebo (SMD = 3.65; 95 % CI 1.56–5.75), though no significant difference was found in response rate (RR = 0.04, 95 % CI −0.06 to 0.14) and RFS (SMD = 0.91; 95 % CI −0.53 to 2.35) between these two groups of patients. No publication bias was found among eligible studies. PPI treatment could significantly improve reflux symptoms in LPR patients and, therefore, should be taken into consideration for LPR management with other strategies, such as lifestyle modification.
KeywordsProton pump inhibitor Laryngopharyngeal reflux Meta-analysis
Compliance with ethical standards
Conflict of interest
All the authors declare that they have no conflict of interest.
This article does not contain any studies with human participants or animals performed by any of the authors.
- 7.Koufman JA, Aviv JE, Casiano RR, Shaw GY (2002) Laryngopharyngeal reflux: position statement of the committee on speech, voice, and swallowing disorders of the American Academy of Otolaryngology-Head and Neck Surgery. Otolaryngol Head Neck Surg Off J Am Acad Otolaryngol Head Neck Surg 127(1):32–35CrossRefGoogle Scholar
- 9.Reichel O, Keller J, Rasp G, Hagedorn H, Berghaus A (2007) Efficacy of once-daily esomeprazole treatment in patients with laryngopharyngeal reflux evaluated by 24-h pH monitoring. Otolaryngol Head Neck Surg Off J Am Acad Otolaryngol Head Neck Surg 136(2):205–210. doi: 10.1016/j.otohns.2006.10.011 CrossRefGoogle Scholar
- 14.Chappity P, Kumar R, Deka RC, Chokkalingam V, Saraya A, Sikka K (2014) Proton pump inhibitors versus solitary lifestyle modification in management of laryngopharyngeal reflux and evaluating who is at risk: scenario in a developing country. Clin Med Insights Ear Nose Throat 7(7):1–5CrossRefPubMedPubMedCentralGoogle Scholar
- 16.Lam PK, Ng ML, Cheung TK, Wong BY, Tan VP, Fong DY, Wei WI, Wong BC (2010) Rabeprazole is effective in treating laryngopharyngeal reflux in a randomized placebo-controlled trial. Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc 8(9):770–776Google Scholar
- 17.Fass R, Noelck N, Willis MR, Navarro-Rodriguez T, Wilson K, Powers J, Barkmeier-Kraemer JM (2010) The effect of esomeprazole 20 mg twice daily on acoustic and perception parameters of the voice in laryngopharyngeal reflux. Neurogastroenterol Motil Off J Eur Gastrointest Motil Soc 22(2):44–45Google Scholar
- 18.Ours TM, Kavuru MS, Schilz RJ, Richter JE (1999) A prospective evaluation of esophageal testing and a double-blind, randomized study of omeprazole in a diagnostic and therapeutic algorithm for chronic cough. Am J Gastroenterol 94(11):3131–3138. doi: 10.1111/j.1572-0241.1999.01504.x CrossRefPubMedGoogle Scholar
- 25.Shaheen NJ, Crockett SD, Bright SD, Madanick RD, Buckmire R, Couch M, Dellon ES, Galanko JA, Sharpless G, Morgan DR (2011) Randomised clinical trial: high-dose acid suppression for chronic cough—a double-blind, placebo-controlled study. Aliment Pharmacol Ther 33(2):225–234CrossRefPubMedGoogle Scholar
- 26.Luo H, Ma S, Gao Y, Yan J, Hou J, Xu M (2015) The therapeutic effect of proton pump inhibitor on alleviation of hoarseness symptoms in patients with laryngopharyngeal reflux. J Clin Otorhinolaryngol Head Neck Surg 29(11):997–1001Google Scholar